<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1670</article-id><article-id pub-id-type="doi">10.15789/2220-7619-ACR-1670</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">A controversial role of neutrophils in tuberculosis infection pathogenesis</article-title><trans-title-group xml:lang="ru"><trans-title>Нейтрофилы: неоднозначная роль в патогенезе туберкулеза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1535-5800</contrib-id><name-alternatives><name xml:lang="en"><surname>Linge</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Линге</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Irina A. Linge, </bold> PhD (Biology), Senior Researcher, Laboratory of Immunogenetics, Immunology Department </p><p>107564, Moscow, Yauzskaya alley, 2</p><p>Phone: +7 499 785-90-72 </p></bio><bio xml:lang="ru"><p><bold>Линге Ирина Андреевна, </bold> к.б.н., старший научный сотрудник лаборатории иммуногенетики отдела иммунологии </p><p>107564, Москва, Яузская аллея, 2,</p><p>Тел.: 8 499 785-90-72</p></bio><email>iralinge@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3683-3085</contrib-id><name-alternatives><name xml:lang="en"><surname>Apt</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Апт</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Biology), Professor, Head of the Laboratory of Immunogenetics, Immunology Department </p><p>Moscow</p></bio><bio xml:lang="ru"><p>д.б.н., профессор, зав. лабораторией иммуногенетики отдела иммунологии </p><p>Москва</p></bio><email>alexapt0151@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central Tuberculosis Research Institute</institution></aff><aff><institution xml:lang="ru">ФГБНУ Центральный НИИ туберкулеза</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-11-21" publication-format="electronic"><day>21</day><month>11</month><year>2021</year></pub-date><volume>11</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>809</fpage><lpage>819</lpage><history><date date-type="received" iso-8601-date="2021-01-22"><day>22</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-08-16"><day>16</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Linge I.A., Apt A.S.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Линге И.А., Апт А.С.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Linge I.A., Apt A.S.</copyright-holder><copyright-holder xml:lang="ru">Линге И.А., Апт А.С.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/1670">https://iimmun.ru/iimm/article/view/1670</self-uri><abstract xml:lang="en"><p>Tuberculosis (TB) continues to be an important and unresolved medical problem. About a quarter of mankind is infected with Mycobacterium tuberculosis, and about 5–10% of these people eventually develop TB. Macrophages and CD4<sup>+</sup> T cells are considered the key cells providing defense against TB infection. The role of neutrophils in TB is less well defined. Neutrophils are short-lived granulocytes among first migrate into the infectious lung tissue and phagocy tose mycobacteria. On the one hand, there is evidence for protective role of neutrophils in TB released via anti-microbial peptides inhibiting mycobacterial growth, up-regulation of CD4<sup>+</sup> T-cell activation, and dendritic cell migration in the lymph nodes. On the other hand, infection of genetically TB susceptible animals leads to an overwhelming lung neutrophil inflammation, development of necrotic granulomata, and a rapid death. Neutrophils act directly or indirectly on mycobacteria by different oxidative or other reactions including neutrophil extracellular traps (NETs) formation. Phagocytosis of mycobacteria by neutrophils is accompanied by the production of pro-inflammatory factors, thus making neutrophils active participants of inflammation in all stages of the infectious process. Finally, neutrophils die by apoptosis or necrosis. Necrosis of neutrophils, which is activated by reactive oxygen species, also prolongs the inflammation. In this way, there is strong evidence that neutrophils are the cells involved in the transition of infection to the terminal stage, participating in lung tissue destruction. Although neutrophils evolutionary developed many ways to resist pathogens, it is likely, that neutrophils do not possess sufficient anti-mycobactericidal capacities due to the development of many adaptations allowing mycobacteria to survive inside the neutrophils. Neutrophils effectively phagocytose but poorly kill mycobacteria, thus hiding bacilli from more efficient killers, macrophages, and playing the role of the “Trojan Horse”. In this review, we summarize the data on the involvement of neutrophils in TB inflammation. We discuss their ambiguous role in pathogenesis which depends upon mycobacterial virulence, host genetics, dynamics of migration to inflammatory foci, and persistence during initial and chronic stages of the infectious process.</p></abstract><trans-abstract xml:lang="ru"><p>Туберкулез (ТБ) до сих пор является важной нерешенной медицинской проблемой. Примерно четверть человечества заражена Mycobacterium tuberculosis, и у 5–10% рано или поздно развивается ТБ. Макрофаги и Т-лимфоциты CD4<sup>+</sup> являются основными иммунными клетками, противостоящими ТБ-инфекции. Гораздо меньше известно о роли нейтрофилов при ТБ. Нейтрофилы, короткоживущие лейкоциты, в числе первых реагируют на проникновение инфекции, мигрируют в очаг воспаления и поглощают микобактерии в легких. С одной стороны, есть свидетельства защитной роли нейтрофилов за счет продукции пептидов, подавляющих рост микобактерий, усиления активации Т-лимфоцитов CD4<sup>+</sup> и миграции дендритных клеток в лимфоузлы. С другой стороны, инфицирование генетически чувствительных к ТБ животных приводит к избыточному притоку нейтрофилов в легкие, формированию некротических гранулем и быстрой гибели. Нейтрофилы напрямую или опосредованно воздействуют на микобактерии, используя различные окислительные и неокислительные реакции, а также образуя нейтрофильные внеклеточные ловушки (NETs). Фагоцитоз микобактерий нейтрофилами стимулирует выделение ими множества провоспалительных медиаторов, поэтому нейтрофилы являются активными участниками воспаления на всех стадиях развития инфекционного процесса. В конечном итоге нейтрофилы погибают путем апоптоза или некроза. Гибель нейтрофилов путем некроза, инициируемого активными формами кислорода, в свою очередь также провоцирует излишнее воспаление. В связи с этим велика вероятность того, что именно нейтрофилы способствуют переходу ТБ в терминальную стадию, участвуя в распаде легочной ткани. Кроме того, несмотря на то что эволюционно нейтрофилы имеют достаточно возможностей воздействия на патоген, по-видимому, сами по себе они не обладают достаточной бактерицидной активностью в отношении микобактерий вследствие формирования у последних механизмов защиты, позволяющих выживать внутри клеток. Таким образом, нейтрофилы фагоцитируют, но не убивают микобактерии и могут выступать в роли «троянского коня», экранируя бактерии от более эффективных защитных действий макрофагов. В этом обзоре мы обобщаем данные последних лет об участии нейтрофилов в туберкулезном воспалении. Мы обсуждаем неоднозначность их роли в патогенезе в зависимости от вирулентости микобактерий и генетических особенностей хозяина, динамику притока нейтрофилов в очаг воспаления и персистирование в начальной и хронической стадиях инфекции.</p></trans-abstract><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>Mycobacterium tuberculosis</kwd><kwd>neutrophils</kwd><kwd>lung inflammation</kwd><kwd>immune response</kwd><kwd>chemoattractants</kwd><kwd>antimycobacterial agents</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>Mycobacterium tuberculosis</kwd><kwd>нейтрофилы</kwd><kwd>легочное воспаление</kwd><kwd>иммунный ответ</kwd><kwd>хемоаттрактанты</kwd><kwd>антимикобактериальные агенты</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Abadie V., Badell E., Douillard P., Ensergueix D., Leenen P.J.M., Tanguy M., Fiette L., Saeland S., Gicquel B., Winter N. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood, 2005, vol. 106, pp. 1843–1850. doi: 10.1182/blood-2005-03-1281</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Bazzoni F., Cassatella M.A., Rossi F., Ceska M., Dewald B., Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J. Exp. Med., 1991, vol. 173, pp. 771–774. doi: 10.1084/jem.173.3.771</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Berry M.P.R., Graham C.M., McNab F.W., Xu Z., Bloch S.A.A., Oni T., Wilkinson K.A., Banchereau R., Skinner J., Wilkinson R.J., Quinn C., Blankenship D., Dhawan R., Cush J.J., Mejias A., Ramilo O., Kon O.M., Pascual V., Banchereau J., Chaussabel D., O’Garra A. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 2010, vol. 466, pp. 973–977. doi: 10.1038/nature09247</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Blomgran R., Desvignes L., Briken V., Ernst J.D. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe, 2012, vol. 11, pp. 81–90. doi: 10.1016/j.chom.2011.11.012</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Blomgran R., Ernst J.D. Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J. Immunol., 2011, vol. 186, pp. 7110–7119. doi: 10.4049/jimmunol.1100001</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Bober L.A., Grace M.J., Pugliese-Sivo C., Rojas-Triana A., Waters T., Sullivan L.M., Narula S.K. The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology, 1995, vol. 29, pp. 111–119. doi: 10.1016/0162-3109(94)00050-P</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Braian C., Hogea V., Stendahl O. Mycobacterium tuberculosis-induced neutrophil extracellular traps activate human macrophages. J. Innate Immun., 2013, vol. 5, pp. 591–602. doi: 10.1159/000348676</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science, 2004, vol. 303, pp. 1532–1535. doi: 10.1126/science.1092385</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Castillo E.F., Dekonenko A., Arko-Mensah J., Mandell M.A., Dupont N., Jiang S., Delgado-Vargas M., Timmins G.S., Bhattacharya D., Yang H., Hutt J., Lyons C.R., Dobos K.M., Deretic V. Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proc. Natl. Acad. Sci. USA, 2012, vol. 109, no. 46, pp. E3168– E3176. doi: 10.1073/pnas.1210500109</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Choi H., Chon H.R., Kim K., Kim S., Oh K.J., Jeong S.H., Jung W.J., Shin B., Jhun B.W., Lee H., Park H.Y., Koh W.J. Clinical and laboratory differences between lymphocyte- and neutrophil-predominant pleural tuberculosis. PLoS One, 2016, vol. 11, no. 10: e0165428. doi: 10.1371/journal.pone.0165428</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Choreño-Parra J.A., Bobba S., Rangel-Moreno J., Ahmed M., Mehra S., Rosa B., Martin J., Mitreva M., Kaushal D., Zúñiga J., Khader S.A. Mycobacterium tuberculosis HN878 infection induces human-like B-cell follicles in mice. J. Infect. Dis., 2020, vol. 221, pp. 1636–1646. doi: 10.1093/infdis/jiz663</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Cohen S.B., Gern B.H., Delahaye J.L., Adams K.N., Plumlee C.R., Winkler J.K., Sherman D.R., Gerner M.Y., Urdahl K.B. Alveolar macrophages provide an early Mycobacterium tuberculosis niche and initiate dissemination. Cell Host Microbe, 2018, vol. 24, pp. 439–446. doi: 10.1016/j.chom.2018.08.001</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Condliffe A.M., Chilvers E.R., Haslett C., Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology, 1996, vol. 89, pp. 105–111. doi: 10.1046/j.1365-2567.1996.d01-711.x</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Corleis B., Korbel D., Wilson R., Bylund J., Chee R., Schaible U.E. Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils. Cell Microbiol., 2012, vol. 14, pp. 1109–1121. doi: 10.1111/j.1462-5822.2012.01783.x</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Dallenga T., Repnik U., Corleis B., Eich J., Reimer R., Griffiths G.W., Schaible U.E. M. tuberculosis-induced necrosis of infected neutrophils promotes bacterial growth following phagocytosis by macrophages. Cell Host Microbe, 2017, vol. 22, pp. 519.e3–530.e3. doi: 10.1016/j.chom.2017.09.003</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Dapino P., Dallegri F., Ottonello L., Sacchetti C. Induction of neutrophil respiratory burst by tumour necrosis factor-alpha; priming effect of solid-phase fibronectin and intervention of CD llb-CD18 integrins. Clin. Exp. Immunol., 2008, vol. 94, pp. 533–538. doi: 10.1111/j.1365-2249.1993.tb08230.x</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Das R., Koo M.S., Kim B.H., Jacob S.T., Subbian S., Yao J., Leng L., Levy R., Murchison C., Burman W.J., Moore C.C., Michael Scheld W., David J.R., Kaplan G., MacMicking J.D., Bucala R. Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA, 2013, vol. 110: E2997. doi: 10.1073/pnas.1301128110</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Deffert C., Cachat J., Krause K.H. Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections. Cell Microbiol., 2014, vol. 16, pp. 1168–1178. doi: 10.1111/cmi.12322</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. DeLeo F.R. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis, 2004, vol. 9, pp. 399–413. doi: 10.1023/B:APP T.0000031448.64969.fa</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Desvignes L., Ernst J.D. Interferon-γ-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity, 2009, vol. 31, pp. 974–985. doi: 10.1016/j.immuni.2009.10.007</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Dorhoi A., Desel C., Yeremeev V., Pradl L., Brinkmann V., Mollenkopf H.J., Hanke K., Gross O., Ruland J., Kaufmann S.H.E. The adaptor molecule CARD9 is essential for tuberculosis control. J. Exp. Med., 2010, vol. 207, pp. 777–792. doi: 10.1084/jem.20090067</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. Dorhoi A., Iannaccone M., Farinacci M., Faé K.C., Schreiber J., Moura-Alves P., Nouailles G., Mollenkopf H.J., OberbeckMüller D., Jörg S., Heinemann E., Hahnke K., Löwe D., Del Nonno F., Goletti D., Capparelli R., Kaufmann S.H.E. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J. Clin. Invest., 2013, vol. 123, pp. 4836–4848. doi: 10.1172/JCI67604</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. Ellison M.A., Gearheart C.M., Porter C.C., Ambruso D.R. IFN-γ alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils. PLoS One, 2017, vol. 12: e0185956. doi: 10.1371/journal.pone.0185956</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24. Eruslanov E.B., Lyadova I.V., Kondratieva T.H., Majorov K.B., Scheglov I.V., Orlova M.O., Apt A.S. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect. Immun., 2005, vol. 73, pp. 1744–1753. doi: 10.1128/IAI.73.3.1744</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25. Ethuin F., Gérard B., Benna J.E., Boutten A., Gougereot-Pocidalo M.A., Jacob L., Chollet-Martin S. Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab. Investig., 2004, vol. 84, pp. 1363–1371. doi: 10.1038/labinvest.3700148</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26. Eum S.Y., Kong J.H., Hong M.S., Lee Y.J., Kim J.H., Hwang S.H., Cho S.H., Via S.N., Laura E., Clifton B.E. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest, 2010, vol. 137, pp. 122–128. doi: 10.1378/chest.09-0903</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27. Francis R.J., Butler R.E., Stewart G.R. Mycobacterium tuberculosis ESAT-6 is a leukocidin causing Ca2+ influx, necrosis and neutrophil extracellular trap formation. Cell Death Dis., 2014, vol. 5: e1474. doi: 10.1038/cddis.2014.394</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28. Futosi K., Fodor S., Mócsai A. Reprint of neutrophil cell surface receptors and their intracellular signal transduction pathways. Int. Immunopharmacology, 2013, vol. 17, pp. 1185–1197. doi: 10.1016/j.intimp.2013.11.010</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29. Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol., 2003, vol. 3, pp. 710–720. doi: 10.1038/nri1180</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30. Gopal R., Monin L., Torres D., Slight S., Mehra S., McKenna K.C., Junecko B.A.F., Reinhart T.A., Kolls J., Báez-Saldańa R., Cruz-Lagunas A., Rodríguez-Reyna T.S., Kumar N.P., Tessier P., Roth J., Selman M., Becerril-Villanueva E., BaqueraHeredia J., Cumming B., Kasprowicz V.O., Steyn A.J.C., Babu S., Kaushal D., Zúñiga J., Vogl T., Rangel-Moreno J., Khader Sh.A. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. Am. J. Respir. Crit. Care Med., 2013, vol. 188, pp. 1137–1146. doi: 10.1164/rccm.201304-0803OC</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31. Alvarez-Jiménez V.D., Leyva-Paredes K., Campillo-Navarro M., Romo-Cruz I., Hugo Rosales-García V., CastañedaCasimiro J., González-Pozos S., Manuel Hernández J., Wong-Baeza C., Estela García-Pérez B., Ortiz-Navarrete V., EstradaParra S., Serafín-López J., Wong-Baeza I., Estrada-García I. Extracellular vesicles released from Mycobacterium tuberculosisinfected neutrophils promote macrophage autophagy and decrease intracellular mycobacterial survival. Front. Immunol., 2018, vol. 9: 272. doi: 10.3389/fimmu.2018.00272</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32. Hilda J.N., Das S., Tripathy S.P., Hanna L.E. Role of neutrophils in tuberculosis: a bird’s eye view. Innate Immun., 2020, vol. 26, no. 4, pp. 240–247. doi: 10.1177/1753425919881176</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33. Jena P., Mohanty S., Mohanty T., Kallert S., Morgelin M., Lindstrøm T., Borregaard N., Stenger S., Sonawane A., Sørensen O.E. Azurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages. PLoS One, 2012, vol. 7: e50345. doi: 10.1371/journal.pone.0050345</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34. Jin L., Batra S., Douda D.N., Palaniyar N., Jeyaseelan S. CXCL1 contributes to host defense in polymicrobial sepsis via modulating T cell and neutrophil functions. J. Immunol., 2014, vol. 193, pp. 3549–3558. doi: 10.4049/jimmunol.1401138</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35. Keller C., Hoffmann R., Lang R., Brandau S., Hermann C., Ehlers S. Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect. Immun., 2006, vol. 74, pp. 4295–4309. doi: 10.1128/IAI.00057-06</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36. Kimmey J.M., Huynh J.P., Weiss L.A., Park S., Kambal A., Debnath J., Virgin H.W., Stallings C.L. Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection. Nature, 2015, vol. 528, pp. 565–569. doi: 10.1038/nature16451</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37. Kondratieva T.K., Rubakova E.I., Linge I.A., Evstifeev V.V., Majorov K.B., Apt A.S. B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective Bacillus Calmette–Guerin vaccination against tuberculosis infection in mice. J. Immunol., 2010, vol. 184, pp. 1227–1234. doi: 10.4049/jimmunol.0902011</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38. Kroon E.E., Coussens A.K., Kinnear C., Orlova M., Möller M., Seeger A., Wilkinson R.J., Hoal E.G., Schurr E. Neutrophils: innate effectors of TB resistance? Front. Immunol., 2018, vol. 9: 2637. doi: 10.3389/fimmu.2018.02637</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39. Law K., Weiden M., Harkin T., Tchou-Wong K., Chi C., Rom W.N. Increased release of interleukin-1β, interleukin-6, and tumor necrosis factor-α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med., 1996, vol. 153, pp. 799–804. doi: 10.1164/ajrccm.153.2.8564135</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40. Liles W.C., Ledbetter J.A., Waltersdorph A.W., Klebanoff S.J. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: Implications for adhesion-dependent physiological responses in neutrophils. J. Leukoc. Biol., 1995, vol. 58, pp. 690–697. doi: 10.1002/jlb.58.6.690</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41. Lovewell R.R., Baer C.E., Mishra B.B., Smith C.M., Sassetti C.M. Granulocytes act as a niche for Mycobacterium tuberculosis growth. Mucosal Immunol., 2020, vol. 14, pp. 229–241. doi: 10.1038/s41385-020-0300-z</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42. Lowe D.M., Bandara A.K., Packe G.E., Barker R.D., Wilkinson R.J., Griffiths C.J., Martineau A.R. Neutrophilia independently predicts death in tuberculosis. Eur. Respir. J., 2013, vol. 42, pp. 1752–1757. doi: 10.1183/09031936.00140913</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43. Lowe D.M., Demaret J., Bangani N., Nakiwala J.K., Goliath R., Wilkinson K.A., Wilkinson R.J., Martineau A.R. Differential effect of viable versus necrotic neutrophils on mycobacterium tuberculosis growth and cytokine induction in whole blood. Front. Immunol., 2018, vol. 9: 27. doi: 10.3389/fimmu.2018.00903</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44. Lyadova I.V. Review article neutrophils in tuberculosis: heterogeneity shapes the way? Mediators Inflamm., 2017, vol. 2017: 8619307. doi: 10.1155/2017/8619307</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45. Martineau A.R., Newton S.M., Wilkinson K.A., Kampmann B., Hall B.M., Nawroly N., Packe G., Davidson R.N., Griffiths C.J., Wilkinson R.J. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Invest., 2007, vol. 117, pp. 1988–1994. doi: 10.1172/JCI31097</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46. Marzo E., Vilaplana C., Tapia G., Diaz J., Garcia V., Cardona P.-J. Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. Tuberculosis, 2014, vol. 94, pp. 55–64. doi: 10.1016/j.tube.2013.09.004</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>47. Mayadas T.N., Cullere X., Lowell C.A. The Multifaceted functions of neutrophils. Annu. Rev. Pathol., 2014, vol. 9, pp. 181–218. doi: 10.1146/annurev-pathol-020712-164023</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>48. McCracken J.M., Allen L.A.H. Regulation of human neutrophil apoptosis and lifespan in health and disease. J. Cell Death, 2014, vol. 7, pp. 15–23. doi: 10.4137/JCD.S11038</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>49. Miralda I., Uriarte S.M., McLeish K.R. Multiple phenotypic changes define neutrophil priming. Front. Cell. Infect. Microbiol., 2017, vol. 7: 217. doi: 10.3389/fcimb.2017.00217</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>50. Mitra S., Abraham E. Participation of superoxide in neutrophil activation and cytokine production. Biochim. Biophys. Acta-Mol. Basis. Dis., 2006, vol. 1762, pp. 732–741. doi: 10.1016/j.bbadis.2006.06.011</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>51. Muefong C.N., Sutherland J.S. Neutrophils in tuberculosis-associated inflammation and lung pathology. Front. Immunol., 2020, vol. 11: 962. doi: 10.3389/fimmu.2020.00962</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>52. N’Diaye E.-N., Darzacq X., Astarie-Dequeker C., Daffé M., Calafat J., Maridonneau-Parini I. Fusion of azurophil granules with phagosomes and activation of the tyrosine kinase hck are specifically inhibited during phagocytosis of mycobacteria by human neutrophils. J. Immunol., 1998, vol. 161, pp. 4983–4991.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>53. Nandi B., Behar S.M. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J. Exp. Med., 2011, vol. 208, pp. 2251–2262. doi: 10.1084/jem.20110919</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>54. Nathan C. Points of control in inflammation. Nature, 2002, vol. 420, pp. 846–852. doi: 10.1038/nature01320</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>55. Nathan C., Cunningham-Bussel A. Beyond oxidative stress: an immunologist’s guide to reactive oxygen species. Nat. Rev. Immunol., 2013, vol. 13, pp. 349–361. doi: 10.1038/nri3423</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>56. Neufert C., Pai R.K., Noss E.H., Berger M., Boom W.H., Harding C.V. Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. J. Immunol., 2001, vol. 167, pp. 1542–1549. doi: 10.4049/jimmunol.167.3.1542</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>57. Niazi M.K.K., Dhulekar N., Schmidt D., Major S., Cooper R., Abeijon C., Gatti D.M., Kramnik I., Yener B., Gurcan M., Beamer G. Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice. Dis. Model. Mech., 2015, vol. 8, pp. 1141–1153. doi: 10.1242/dmm.020867</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>58. Nouailles G., Dorhoi A., Koch M., Zerrahn J., Weiner J., Faé K.C., Arrey F., Kuhlmann S., Bandermann S., Loewe D., Mollen kopf H.J., Vogelzang A., Meyer-Schwesinger C., Mittrücker H.W., McEwen G., Kaufmann S.H.E. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J. Clin. Invest., 2014, vol. 124, pp. 1268–1282. doi: 10.1172/JCI72030</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>59. O’Garra A., Redford P.S., McNab F.W., Bloom C.I., Wilkinson R.J., Berry M.P.R. The immune response in tuberculosis. Annu. Rev. Immunol., 2013, vol. 31, pp. 475–527. doi: 10.1146/annurev-immunol-032712-095939</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>60. Papayannopoulos V., Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol., 2009, vol. 30, pp. 513–521. doi: 10.1016/j.it.2009.07.011</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>61. Petrofsky M., Bermudez L.E. Neutrophils from Mycobacterium avium-infected mice produce TNFα, IL-12, and IL-1β and have a putative role in early host response. Clin. Immunol., 1999, vol. 91, pp. 354–358. doi: 10.1006/clim.1999.4709</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>62. Riedel D.D., Kaufmann S.H.E. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with mycobacterium tuberculosis and lipoarabinomannan. Infect. Immun., 1997, vol. 65, pp. 4620–4623. doi: 10.1128/IAI.65.11.4620-4623.1997</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>63. Rivas-Santiago B., Hernandez-Pando R., Carranza C., Juarez E., Contreras J.L., Aguilar-Leon D., Torres M., Sada E. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect. Immun., 2008, vol. 76, pp. 935–941. doi: 10.1128/IAI.01218-07</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>64. Russell D.G. Mycobacterium tuberculosis: here today, and here tomorrow. Nat. Rev. Mol. Cell Biol., 2001, vol. 2, pp. 569–577. doi: 10.1038/35085034</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>65. Russell D.G. Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol., 2007, vol. 5, pp. 39–47. doi: 10.1038/nrmicro1538</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>66. Ryckman C., McColl S.R., Vandal K., De Médicis R., Lussier A., Poubelle P.E., Tessier P.A. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum., 2003, vol. 48, pp. 2310–2320. doi: 10.1002/art.11079</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>67. Sakai S., Kauffman K.D., Sallin M.A., Sharpe A.H., Young H.A., Ganusov V.V., Barber V.V., Daniel L. CD4 T cell-derived IFN-γ plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease. PLoS Pathog., 2016, vol. 12, no. 5: e1005667. doi: 10.1371/journal.ppat.1005667</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>68. Sawant K.V., McMurray D.N. Guinea pig neutrophils infected with Mycobacterium tuberculosis produce cytokines which activate alveolar macrophages in noncontact cultures. Infect. Immun., 2007, vol. 75, pp. 1870–1877. doi: 10.1128/IAI.00858-06</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>69. Schneider B.E., Korbel D., Hagens K., Koch M., Raupach B., Enders J., Kaufmann S.H.E., Mittrücker H.W., Schaible U.E. A role for IL-18 in protective immunity against Mycobacterium tuberculosis. Eur. J. Immunol., 2010, vol. 40, pp. 396–405. doi: 10.1002/eji.200939583</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>70. Scott N.R., Swanson R.V., Al-Hammadi N., Domingo-Gonzalez R., Rangel-Moreno J., Kriel B.A., Domingo-Gonzalez R., Rangel-Moreno J., Kriel B.A., Bucsan A.N., Das S., Ahmed M., Mehra S., Treerat P., Cruz-Lagunas A., Jimenez-Alvarez L., Muñoz-Torrico M., Bobadilla-Lozoya K., Vogl T., Walzl G., du Plessis N., Kaushal D., Scriba T., Zuñiga J., Khader S. S100A8/ A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis. J. Clin. Invest., 2020, vol. 130, no. 6, pp. 3098–3112. doi: 10.1172/JCI130546</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>71. Seiler P., Aichele P., Raupach B., Odermatt B., Steinhoff U., Kaufmann S.H.E. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. J. Infect. Dis., 2000, vol. 181, pp. 671–680. doi: 10.1086/315278</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>72. Sharma S., Verma I., Khuller G.K. Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis. Antimicrob. Agents Chemother., 2001, vol. 45, pp. 639–640. doi: 10.1128/AAC.45.2.639-640.2001</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>73. Shea-Donohue T., Thomas K., Cody M.J., Zhao A., Detolla L.J., Kopydlowski K.M., Fukata M., Lira S.A., Vogel S.N. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-α), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun., 2008, vol. 14, pp. 117–124. doi: 10.1177/1753425908088724</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>74. Spiekermann K., Roesler J., Emmendoerffer A., Elsner J., Welte K. Functional features of neutrophils induced by G-CSF and GMCSF treatment: Differential effects and clinical implications. Leukemia, 1997, vol. 11, pp. 466–478. doi: 10.1038/sj.leu.2400607</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>75. Stamm C.E., Collins A.C., Shiloh M.U. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus. Immunol. Rev., 2015, vol. 264, pp. 204–219. doi: 10.1111/imr.12263</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>76. Steinwede K., Maus R., Bohling J., Voedisch S., Braun A., Ochs M., Schmiedl A., Länger F., Gauthier F., Roes J., Welte T., Bange F.C., Niederweis M., Bühling F., Maus U.A. Cathepsin G and neutrophil elastase contribute to lung-protective immunity against mycobacterial infections in mice. J. Immunol., 2012, vol. 188, pp. 4476–4487. doi: 10.4049/jimmunol.1103346</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>77. Stek C., Allwood B., Walker N.F., Wilkinson R.J., Lynen L., Meintjes G. The immune mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed therapy. Front. Microbiol., 2018, vol. 9: 2603. doi: 10.3389/fmicb.2018.02603</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>78. Strieter R.M., Kasahara K., Allen R.M., Standiford T.J., Rolfe M.W., Becker F.S., Chensue S.W., Kunkel S.L. Cytokine-induced neutrophil-derived interleukin-8. Am. J. Pathol., 1992, vol. 141, pp. 397–407. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1886610</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>79. Sugawara I., Udagawa T., Yamada H. Rat neutrophils prevent the development of tuberculosis. Infect. Immun., 2004, vol. 72, pp. 1804–1806. doi: 10.1128/IAI.72.3.1804-1806.2004</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>80. Summers C., Rankin S.M., Condliffe A.M., Singh N., Peters A.M., Chilvers E.R. Neutrophil kinetics in health and disease. Trends Immunol., 2010, vol. 31, pp. 318–324. doi: 10.1016/j.it.2010.05.006</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>81. Sunahori K., Yamamura M., Yamana J., Takasugi K., Kawashima M., Yamamoto H., Chazin W.J., Nakatani Y., Yui S., Makino H. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res. Ther., 2006, vol. 8: 69. doi: 10.1186/ar1939</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>82. Sutherland J.S., Jeffries D.J., Donkor S., Walther B., Hill P.C., Adetifa I.M.O., Adegbola I.M.O., Ota R.A., Martin O.C. High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting. Tuberculosis, 2009, vol. 89, pp. 398–404. doi: 10.1016/j.tube.2009.07.004</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>83. Tan B.H., Meinken C., Bastian M., Bruns H., Legaspi A., Ochoa M.T., Krutzik S.R., Bloom B.R., Ganz T., Modlin R.L., Stenger S. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J. Immunol., 2006, vol. 177, pp. 1864–1871. doi: 10.4049/jimmunol.177.3.1864</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>84. Trentini M.M., de Oliveira F.M., Kipnis A., Junqueira-Kipnis A.P. The role of neutrophils in the induction of specific Th1 and Th17 during vaccination against tuberculosis. Front. Microbiol., 2016, vol. 7: 898. doi: 10.3389/fmicb.2016.00898</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>85. Ueda Y., Cain D.W., Kuraoka M., Kondo M., Kelsoe G. IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J. Immunol., 2009, vol. 182, pp. 6477–6484. doi: 10.4049/jimmunol.0803961</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>86. Velmurugan K., Chen B., Miller J.L., Azogue S., Gurses S., Hsu T., Glickman M., Jacobs W.R., Porcelli S.A., Briken V. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog., 2007, vol. 3, no. 7: e110. doi: 10.1371/journal.ppat.0030110</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>87. Voskuil M.I., Bartek I.L., Visconti K., Schoolnik G.K. The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front. Microbiol., 2011, vol. 2: 105. doi: 10.3389/fmicb.2011.00105</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>88. Vyas S.P., Goswami R. Striking the right immunological balance prevents progression of tuberculosis. Inflamm. Res., 2017, vol. 66, pp. 1031–1056. doi: 10.1007/s00011-017-1081-z</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>89. Warnatsch A., Tsourouktsoglou T.D., Branzk N., Wang Q., Reincke S., Herbst S., Gutierrez M., Papayannopoulos V. Reactive oxygen species localization programs inflammation to clear microbes of different size. Immunity, 2017, vol. 46, pp. 421–432. doi: 10.1016/j.immuni.2017.02.013</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>90. Weisbart R.H., Golde D.W., Clark S.C., Wong G.G., Gasson J.C. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature, 1985, vol. 314, pp. 361–363. doi: 10.1038/314361a0</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>91. Wengner A.M., Pitchford S.C., Furze R.C., Rankin S.M. The coordinated action of G-CSF and ELR CXC chemokines in neutrophil mobilization during acute inflammation. Blood, 2008, vol. 111, no. 1, pp. 42–49. doi: 10.1182/blood-2007-07-099648</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>92. Witko-Sarsat V., Rieu P., Descamps-Latscha B., Lesavre P., Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab. Investig., 2000, vol. 80, pp. 617–654. doi: 10.1038/labinvest.3780067</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>93. Wolf A.J., Linas B., Trevejo-Nuñez G.J., Kincaid E., Tamura T., Takatsu K., Ernst J.D. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol., 2007, vol. 179, pp. 2509–2519. doi: 10.4049/jimmunol.179.4.2509</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>94. Yang C.T., Cambier C.J., Davis J.M., Hall C.J., Crosier P.S., Ramakrishnan L. Neutrophils exert protection in the early tuberculous granuloma by oxida tive killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe, 2012, vol. 12, pp. 301–312. doi: 10.1016/j.chom.2012.07.009</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>95. Yeremeev V., Linge I., Kondratieva T., Apt A. Neutrophils exacerbate tuberculosis infection in genetically susceptible mice. Tuberculosis, 2015, vol. 95, pp. 447–451. doi: 10.1016/j.tube.2015.03.007</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>96. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol., 2004, vol. 75, pp. 39–48. doi: 10.1189/jlb.0403147</mixed-citation></ref></ref-list></back></article>
